Elyan and Oncodesign Services deal adds to pharma flow; Oman fund eyes UK assets

Oncodesign Services is a contract research organisation specialising in drug discovery and preclinical services in oncology and immuno-inflammation.

To view this content, you need to sign in.

You should only be asked to sign in once. Not the case? Click here

Register now to access this content and more for free.

Share this